Contract HHSN268201600240PC
Adaptive Biotechnologies Corporation · Department Of Health And Human Services · June 2, 2016
Adaptive Biotechnologies Corporation was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on June 2, 2016 for $9,000 of work in research and development in biotechnology. Performance is in Seattle, WA. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSN268201600240PC
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Drugs And Biologicals
- Place of performance
- Seattle, WA
- First action
- June 2, 2016
Description
IMMUNOSEQ HSTCRB KIT, AND QIAGEN MULTIPLEX PCR PLUS KITS
Modification timeline
-
June 2, 2016Base award$8.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN268201600240PC?
Contract HHSN268201600240PC is a federal contract awarded to Adaptive Biotechnologies Corporation by Department Of Health And Human Services on June 2, 2016 for $9,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.
Who won contract HHSN268201600240PC?
Adaptive Biotechnologies Corporation won contract HHSN268201600240PC from Department Of Health And Human Services.
How much is contract HHSN268201600240PC worth?
Contract HHSN268201600240PC has obligated $9,000 to date.